Hsu Jason
SEC insider (Form 3/4/5 filer). CIK 0001895035. Director at Immix Biopharma, Inc. (IMMX). 4 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in LOS ANGELES, CA.
Companies Hsu Jason has filed insider reports for
- Immix Biopharma, Inc. (IMMX): Director
Hsu Jason
CIK: 0001895035
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMMX
Immix Biopharma, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 22, 2026IMMX
Immix Biopharma, Inc.
AwardDirect6.3K shares- - Jun 20, 2025IMMX
Immix Biopharma, Inc.
AwardDirectStock Option (Right to Buy)
33K shares- - Dec 23, 2024IMMX
Immix Biopharma, Inc.
PurchaseDirect40K shares at avg. $2.19$88K - Dec 20, 2024IMMX
Immix Biopharma, Inc.
PurchaseDirect7.7K shares at avg. $2.17$17K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | Award | 6,250 | - | $0 | Direct |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | Award Stock Option (Right to Buy) | 33,000 | - | - | Direct |
| Dec 23, 2024 | IMMX Immix Biopharma, Inc. | Purchase | 40,000 | $2.19 | $87,680 | Direct |
| Dec 20, 2024 | IMMX Immix Biopharma, Inc. | Purchase | 7,700 | $2.17 | $16,678 | Direct |
1-4 of 4 transactions